Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroenhancement of Interpersonal Psychotherapy in Major Depression
2014-001541-24Phase 2Active
- Sponsor
- University Hospital Freiburg
- Start
- Aug 2015
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of d-cycloserine in major depressive disorder (MDD), sponsored by University Hospital Freiburg. Primary endpoint: Change in HAMD score at week 8. Started Aug 2015; status: active.
02
Drugs
d-cycloserine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2014-001541-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001541-24.